KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Depreciation & Amortization (CF) (2016 - 2025)

Acadia Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 16 years, most recently at $202000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $202000.0 for Q4 2025, down 1.94% from a year ago — trailing twelve months through Dec 2025 was $871000.0 (down 3.22% YoY), and the annual figure for FY2025 was $871000.0, down 3.22%.
  • Depreciation & Amortization (CF) for Q4 2025 was $202000.0 at Acadia Pharmaceuticals, down from $227000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for ACAD hit a ceiling of $616000.0 in Q3 2021 and a floor of $202000.0 in Q4 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $380500.0 (2023), compared with a mean of $373300.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 82.25% in 2021 and later plummeted 43.78% in 2024.
  • Acadia Pharmaceuticals' Depreciation & Amortization (CF) stood at $535000.0 in 2021, then decreased by 13.46% to $463000.0 in 2022, then crashed by 41.25% to $272000.0 in 2023, then dropped by 24.26% to $206000.0 in 2024, then decreased by 1.94% to $202000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $202000.0 (Q4 2025), $227000.0 (Q3 2025), and $213000.0 (Q2 2025) per Business Quant data.